Converge Biotech
PrivateLast Round
Grant
Jun 2, 2026
Total Funding Raised
$33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Converge Biotech is a pharmaceutical company that develops and markets branded formulations for chronic care, including critical care, metabolics, and specialty therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Converge Biotech Comparables
Compare Converge Biotech with similar companies based on industry and business-model similarity.
No public comparables are available for Converge Biotech. Request access to learn about comparables coverage.
Request accessConverge Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2026 | ||||
| Series A | Jan 13, 2026 | ||||
| Seed | Nov 20, 2024 |
Key People
Founding team and executive leadership
Converge Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Series A |
| Vintage Investment Partners | Series A |
| Eight Roads Ventures | Seed |
| Gates Foundation | Grant |
| TLV Partners | Series A, Seed |
| Vertex Ventures Israel | Seed |
| Bessemer Venture Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
$25M round led by Bessemer Venture Partners.
- Nov 20, 2024
$5.5M round led by TLV Partners.
Converge Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Converge Biotech's valuation, stock price, and market status.
Is Converge Biotech a public or private company?
Converge Biotech is a private company.
What is the current stock price of Converge Biotech?
Converge Biotech is a private company with no public stock price. Caplight tracks Converge Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Converge Biotech worth (valuation)?
Valuation information for Converge Biotech is not publicly available.
Can I buy Converge Biotech stock?
Converge Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Converge Biotech's last funding round?
Converge Biotech's most recent funding round was Grant on June 2, 2026.
Who are the main investors in Converge Biotech?
Key investors in Converge Biotech include TLV Partners, Bessemer Venture Partners.
Will Converge Biotech IPO soon?
No public IPO plans have been announced for Converge Biotech.
How can I track Converge Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Converge Biotech's secondary market activity and sign up for updates.